日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes

人源可溶性NKG2D配体以时间和模型依赖的方式对肿瘤发生和进展产生不同的影响

Serritella, Anthony V; Saenz-Lopez Larrocha, Pablo; Dhar, Payal; Liu, Sizhe; Medd, Milan M; Jia, Shengxian; Cao, Qi; Wu, Jennifer D

Antibody targeting of E3 ubiquitin ligases for receptor degradation

抗体靶向E3泛素连接酶以降解受体

Hadir Marei # ,Wen-Ting K Tsai # ,Yee-Seir Kee # ,Karen Ruiz ,Jieyan He ,Chris Cox ,Tao Sun ,Sai Penikalapati ,Pankaj Dwivedi ,Meena Choi ,David Kan ,Pablo Saenz-Lopez ,Kristel Dorighi ,Pamela Zhang ,Yvonne T Kschonsak ,Noelyn Kljavin ,Dhara Amin ,Ingrid Kim ,Andrew G Mancini ,Thao Nguyen ,Chunling Wang ,Eric Janezic ,Alexander Doan ,Elaine Mai ,Hongkang Xi ,Chen Gu ,Melanie Heinlein ,Brian Biehs ,Jia Wu ,Isabelle Lehoux ,Seth Harris ,Laetitia Comps-Agrar ,Dhaya Seshasayee ,Frederic J de Sauvage ,Matthew Grimmer ,Jing Li ,Nicholas J Agard ,Felipe de Sousa E Melo

Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy

靶向肿瘤衍生的可溶性 NKG2D 配体 sMIC 的抗体可对 CD8 T 细胞进行双重共刺激,并使 sMIC+ 肿瘤对 PD1/PD-L1 阻断疗法产生反应

Jinyu Zhang, Pablo Saenz-Lopez Larrocha, Bin Zhang, Derek Wainwright, Payal Dhar, Jennifer D Wu

Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease: a case-control study

梅尼埃病中CD16A和CD32 Fcγ受体及循环免疫复合物的多态性:一项病例对照研究

Lopez-Escamez, José A; Saenz-Lopez, Pablo; Gazquez, Irene; Moreno, Antonia; Gonzalez-Oller, Carlos; Soto-Varela, Andrés; Santos, Sofía; Aran, Ismael; Perez-Garrigues, Herminio; Ibañez, Agueda; Lopez-Nevot, Miguel A